{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:42:30Z","timestamp":1788230550205,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10218-8","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:35:29Z","timestamp":1782304529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IGF2BP3 promotes glycolysis of osteosarcoma stem cells by reading RNA m\u2076A to stabilize ENO1 and promote malignant biological behavior of osteosarcoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Binglun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanhe","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"10218_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040976","author":"B Aramini","year":"2022","unstructured":"Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, et al. Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14040976.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10218_CR2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1142\/S0192415X23500489","volume":"51","author":"ZY Chen","year":"2023","unstructured":"Chen ZY, Huang HH, Li QC, Zhan FB, Wang LB, He T, et al. Capsaicin Reduces Cancer Stemness and Inhibits Metastasis by Downregulating SOX2 and EZH2 in Osteosarcoma. Am J Chin Med. 2023a;51(4):1041\u201366.","journal-title":"Am J Chin Med"},{"key":"10218_CR3","doi-asserted-by":"publisher","first-page":"1071675","DOI":"10.3389\/fimmu.2023.1071675","volume":"14","author":"P Chen","year":"2023","unstructured":"Chen P, Xu J, Cui Z, Wu S, Xie T, Zhang X. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. Front Immunol. 2023b;14:1071675.","journal-title":"Front Immunol"},{"key":"10218_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041766","author":"SH Chen","year":"2025","unstructured":"Chen SH, Yu JH, Lin YC, Chang YM, Liu NT, Chen SF. Application of an integrated single-cell and three-dimensional spheroid culture platform for investigating drug resistance heterogeneity and epithelial-mesenchymal transition (EMT) in lung cancer subclones. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26041766.","journal-title":"Int J Mol Sci"},{"key":"10218_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.150142","volume":"347","author":"M Chen","year":"2026","unstructured":"Chen M, Zheng L, Huang D, Wang S, Wen X, Gao Y, et al. RBM15\/IGF2BP3 promotes immune escape in bladder cancer by enhancing m6A modification of PFKFB4. Int J Biol Macromol. 2026;347:150142.","journal-title":"Int J Biol Macromol"},{"key":"10218_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092449","author":"MA Chico","year":"2023","unstructured":"Chico MA, Mesas C, Doello K, Qui\u00f1onero F, Perazzoli G, Ortiz R, et al. Cancer stem cells in sarcomas: in vitro isolation and role as prognostic markers: a systematic review. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15092449.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10218_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024;9(1):170.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10218_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s10637-021-01148-9","volume":"39","author":"QY Du","year":"2021","unstructured":"Du QY, Zhu ZM, Pei DS. The biological function of IGF2BPs and their role in tumorigenesis. Invest New Drugs. 2021;39(6):1682\u201393.","journal-title":"Invest New Drugs"},{"issue":"12","key":"10218_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100697","volume":"4","author":"R Fan","year":"2024","unstructured":"Fan R, Cui C, Kang B, Chang Z, Wang G, Cui Q. A combined deep learning framework for mammalian m6A site prediction. Cell Genom. 2024;4(12):100697.","journal-title":"Cell Genom"},{"issue":"17","key":"10218_CR10","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2011.38.4420","volume":"30","author":"S Ferrari","year":"2012","unstructured":"Ferrari S, Ruggieri P, Cefalo G, Tamburini A, Capanna R, Fagioli F, et al. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG\/OS-1. J Clin Oncol. 2012;30(17):2112\u20138.","journal-title":"J Clin Oncol"},{"key":"10218_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101583","volume":"27","author":"Y He","year":"2023","unstructured":"He Y, Liu Y, Wu D, Chen L, Luo Z, Shi X, et al. Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells. Transl Oncol. 2023;27:101583.","journal-title":"Transl Oncol"},{"issue":"3","key":"10218_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"10218_CR13","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41416-025-03182-3","volume":"133","author":"P Huang","year":"2025","unstructured":"Huang P, He S, Qi Z, Nijiati Y, Wang J, Lin Z, et al. ENO1 promotes cancer metastasis via stimulating metabolism reprogramming in osteosarcoma. Br J Cancer. 2025;133(11):1625\u201339.","journal-title":"Br J Cancer"},{"issue":"10","key":"10218_CR14","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","volume":"21","author":"L Kager","year":"2003","unstructured":"Kager L, Zoubek A, P\u00f6tschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21(10):2011\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"10218_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167549","volume":"1871","author":"LYW Leck","year":"2025","unstructured":"Leck LYW, Abd El-Aziz YS, McKelvey KJ, Park KC, Sahni S, Lane DJR, et al. Cancer stem cells: Masters of all traits. Biochim Biophys Acta Mol Basis Dis. 2025;1871(3):167549.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10218_CR16","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","volume":"11","author":"Z Li","year":"2020","unstructured":"Li Z, Peng Y, Li J, Chen Z, Chen F, Tu J, et al. N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4. Nat Commun. 2020;11(1):2578.","journal-title":"Nat Commun"},{"issue":"1","key":"10218_CR17","doi-asserted-by":"publisher","first-page":"1966969","DOI":"10.1080\/2162402X.2021.1966969","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, Dai L, Huang M, Ma Y, Guo Z, Wang X, et al. Immunoseroproteomic profiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach. Oncoimmunology. 2021;10(1):1966969.","journal-title":"Oncoimmunology"},{"key":"10218_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117486","volume":"180","author":"F Li","year":"2024","unstructured":"Li F, Li Z, Wei C, Xu L, Liang Y, Yan J, et al. Application of hydrogels for targeting cancer stem cells in cancer treatment. Biomed Pharmacother. 2024;180:117486.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10218_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"10218_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119423","author":"X Liu","year":"2023","unstructured":"Liu X, Chen J, Chen W, Xu Y, Shen Y, Xu X. Targeting IGF2BP3 in cancer. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24119423.","journal-title":"Int J Mol Sci"},{"issue":"46","key":"10218_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci. 2024;11(46):e2401399.","journal-title":"Adv Sci"},{"key":"10218_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08845-4","author":"Y Lu","year":"2026","unstructured":"Lu Y, Zeng X, Peng S, Zhan Y, Liu W, Zhao R, et al. PLSCR1 drives chemoresistance in TNBC via METTL3\/IGF2BP3-mediated mRNA stabilization and EGFR-MAPK pathway activation. Cell Death Dis. 2026. https:\/\/doi.org\/10.1038\/s41419-026-08845-4.","journal-title":"Cell Death Dis"},{"key":"10218_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.872253","volume":"13","author":"M Luo","year":"2022","unstructured":"Luo M, Wu S, Ma Y, Liang H, Luo Y, Gu W, et al. Evaluating a panel of autoantibodies against tumor-associated antigens in human osteosarcoma. Front Genet. 2022;13:872253.","journal-title":"Front Genet"},{"issue":"10","key":"10218_CR24","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S1470-2045(16)30214-5","volume":"17","author":"NM Marina","year":"2016","unstructured":"Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncol. 2016;17(10):1396\u2013408.","journal-title":"Lancet Oncol"},{"key":"10218_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098401","author":"SR Martins-Neves","year":"2023","unstructured":"Martins-Neves SR, Sampaio-Ribeiro G, Gomes CMF. Self-renewal and pluripotency in osteosarcoma stem cells\u2019 chemoresistance: notch, hedgehog, and Wnt\/\u03b2-catenin interplay with embryonic markers. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24098401.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10218_CR26","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra2103423","volume":"385","author":"PS Meltzer","year":"2021","unstructured":"Meltzer PS, Helman LJ. New Horizons in the Treatment of Osteosarcoma. N Engl J Med. 2021;385(22):2066\u201376.","journal-title":"N Engl J Med"},{"key":"10218_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113860","volume":"156","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, et al. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response. Biomed Pharmacother. 2022;156:113860.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10218_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.03.005","volume":"1866","author":"IS Mohiuddin","year":"2020","unstructured":"Mohiuddin IS, Wei SJ, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165432.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"7411","key":"10218_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature11331","volume":"488","author":"FL Muller","year":"2012","unstructured":"Muller FL, Colla S, Aquilanti E, Manzo VE, Genovese G, Lee J, et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature. 2012;488(7411):337\u201342.","journal-title":"Nature"},{"issue":"1","key":"10218_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","volume":"24","author":"Y Pan","year":"2025","unstructured":"Pan Y, Yuan C, Zeng C, Sun C, Xia L, Wang G, et al. Cancer stem cells and niches: challenges in immunotherapy resistance. Mol Cancer. 2025;24(1):52.","journal-title":"Mol Cancer"},{"issue":"2","key":"10218_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ymthe.2024.12.003","volume":"33","author":"KM Pilala","year":"2025","unstructured":"Pilala KM, Panoutsopoulou K, Papadimitriou MA, Soureas K, Scorilas A, Avgeris M. Exploring the methyl-verse: dynamic interplay of epigenome and m6A epitranscriptome. Mol Ther. 2025;33(2):447\u201364.","journal-title":"Mol Ther"},{"issue":"2","key":"10218_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ijc.32526","volume":"146","author":"S Piperno-Neumann","year":"2020","unstructured":"Piperno-Neumann S, Ray-Coquard I, Occean BV, Laurence V, Cupissol D, Perrin C, et al. Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006\/Sarcome-09 study. Int J Cancer. 2020;146(2):413\u201323.","journal-title":"Int J Cancer"},{"issue":"9","key":"10218_CR33","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.7150\/jca.92768","volume":"15","author":"S Qin","year":"2024","unstructured":"Qin S, Jin H, Li Y, Chen X, He J, Xiao J, et al. Comprehensive analysis of IGF2BP3 with expression features, prognosis, immune modulation and stemness in hepatocellular carcinoma and pan-cancer. J Cancer. 2024;15(9):2845\u201365.","journal-title":"J Cancer"},{"issue":"1","key":"10218_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s42003-020-0827-2","volume":"3","author":"F Ren","year":"2020","unstructured":"Ren F, Lin Q, Gong G, Du X, Dan H, Qin W, et al. Igf2bp3 maintains maternal RNA stability and ensures early embryo development in zebrafish. Commun Biol. 2020;3(1):94.","journal-title":"Commun Biol"},{"key":"10218_CR35","doi-asserted-by":"publisher","first-page":"1049183","DOI":"10.3389\/fonc.2022.1049183","volume":"12","author":"W Shao","year":"2022","unstructured":"Shao W, Zhao H, Zhang S, Ding Q, Guo Y, Hou K, et al. A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment. Front Oncol. 2022;12:1049183.","journal-title":"Front Oncol"},{"issue":"10","key":"10218_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116330","volume":"44","author":"G Sharma","year":"2025","unstructured":"Sharma G, Gutierrez M, Jones AE, Kapoor S, Jaiswal AK, Neeb ZT, et al. IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation. Cell Rep. 2025;44(10):116330.","journal-title":"Cell Rep"},{"issue":"1","key":"10218_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-020-01190-w","volume":"19","author":"C Shen","year":"2020","unstructured":"Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19(1):72.","journal-title":"Mol Cancer"},{"issue":"46","key":"10218_CR38","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i46.111631","volume":"31","author":"Y Si","year":"2025","unstructured":"Si Y, Tian B, Zhang R, Xuan MD, Liu KY, Jiao J, et al. IGF2BP3 binds to FBXO32 to activate the cyclic guanosine monophosphate-protein kinase G pathway, promoting gastric cancer progression. World J Gastroenterol. 2025;31(46):111631.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10218_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00486-x","volume":"19","author":"D Song","year":"2024","unstructured":"Song D, Wang Q, Yan Z, Su M, Zhang H, Shi L, et al. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1. Biol Direct. 2024;19(1):44.","journal-title":"Biol Direct"},{"issue":"7","key":"10218_CR40","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.7150\/ijbs.70458","volume":"18","author":"CY Sun","year":"2022","unstructured":"Sun CY, Cao D, Du BB, Chen CW, Liu D. The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m(6)A readers in cancer. Int J Biol Sci. 2022;18(7):2744\u201358.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"10218_CR41","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut. 2020;69(7):1193\u2013205.","journal-title":"Gut"},{"issue":"1","key":"10218_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang Y, Patel H, Chen J, Wang J, Chen ZS, et al. Epigenetic modification of m(6)A regulator proteins in cancer. Mol Cancer. 2023;22(1):102.","journal-title":"Mol Cancer"},{"issue":"4","key":"10218_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41419-024-06564-2","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang B, Wang B, Ma J, He JJ, Wang ZH, Li Q, et al. LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination. Cell Death Dis. 2024;15(4):242.","journal-title":"Cell Death Dis"},{"key":"10218_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217194","author":"X Wei","year":"2024","unstructured":"Wei X, Feng J, Chen L, Zhang C, Liu Y, Zhang Y, et al. METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1. Cancer Lett. 2024. https:\/\/doi.org\/10.1016\/j.canlet.2024.217194.","journal-title":"Cancer Lett"},{"issue":"1","key":"10218_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10120-023-01437-7","volume":"27","author":"R Xie","year":"2024","unstructured":"Xie R, Liu L, Lu X, He C, Yao H, Li G. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Gastric Cancer. 2024;27(1):49\u201371.","journal-title":"Gastric Cancer"},{"key":"10218_CR46","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5c16242","author":"X Xie","year":"2026","unstructured":"Xie X, Zhang Y, Li Y, Yan Q, Dong J, Zhang H, et al. Bisphenol A promotes ovarian cancer proliferation and migration through the HK2\/H3K18la\/IGF2BP3 sequential regulatory axis. J Agric Food Chem. 2026. https:\/\/doi.org\/10.1021\/acs.jafc.5c16242.","journal-title":"J Agric Food Chem"},{"key":"10218_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.593706","volume":"10","author":"W Xu","year":"2020","unstructured":"Xu W, Yang W, Wu C, Ma X, Li H, Zheng J. Enolase 1 correlated with cancer progression and immune-infiltrating in multiple cancer types: a pan-cancer analysis. Front Oncol. 2020;10:593706.","journal-title":"Front Oncol"},{"key":"10218_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1138524","volume":"14","author":"Z Xu","year":"2023","unstructured":"Xu Z, Pei C, Cheng H, Song K, Yang J, Li Y, et al. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma. Front Immunol. 2023;14:1138524.","journal-title":"Front Immunol"},{"issue":"1","key":"10218_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","volume":"17","author":"M Xue","year":"2024","unstructured":"Xue M, Dong L, Zhang H, Li Y, Qiu K, Zhao Z, et al. METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation. J Hematol Oncol. 2024;17(1):7.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10218_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-025-03606-1","volume":"45","author":"T Yi","year":"2025","unstructured":"Yi T, He J, Pan M, Wang Y, Lin C, Ye Y, et al. LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradation. J Exp Clin Cancer Res. 2025;45(1):14.","journal-title":"J Exp Clin Cancer Res"},{"issue":"17","key":"10218_CR51","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1158\/0008-5472.CAN-24-0163","volume":"84","author":"W Zhang","year":"2024","unstructured":"Zhang W, Li W, Yin C, Feng C, Liu B, Xu H, et al. PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT. Cancer Res. 2024;84(17):2873\u201387.","journal-title":"Cancer Res"},{"issue":"1","key":"10218_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40659-025-00659-6","volume":"59","author":"F Zhang","year":"2025","unstructured":"Zhang F, Cheng F, He Z, Zhao C. Hsa_circ_0003611 hinders the transformation of mesenchymal stem cells into osteosarcoma cells through suppressing MYC by IGF2BP3 via m(6)A modification. Biol Res. 2025;59(1):2.","journal-title":"Biol Res"},{"key":"10218_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1416472","volume":"12","author":"J Zhao","year":"2024","unstructured":"Zhao J, Jin D, Huang M, Ji J, Xu X, Wang F, et al. Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target. Front Cell Dev Biol. 2024;12:1416472.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10218_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","volume":"11","author":"TY Zhu","year":"2023","unstructured":"Zhu TY, Hong LL, Ling ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res. 2023;11(1):62.","journal-title":"Biomark Res"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10218-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:02:31Z","timestamp":1784196151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10218-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10218"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10218-8","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained for collection and use of clinical data and tissues from all subjects of the study. All experimental protocols involving human participants in this study were approved by the Medical Ethics Committee of the Shengjing Hospital of the China Medical University (Procedure No. 2025PS085K). All experimental procedures involving animals were performed in accordance to the Animal Welfare Law of China and the Guidelines for Animal Experiment of the China Medical University. This study was approved by the Medical Ethics Committee of the Shengjing Hospital of the China Medical University (Process No. 2024PS1866K).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}